Generic antiretrovirals and the uncertain future of HIV care in the United States

Editorial

Renslow Sherer. Ann Intern Med. 2013.

. 2013 Jan 15;158(2):133-4.

doi: 10.7326/0003-4819-158-2-201301150-00010.

No abstract available

Comment in

Generic antiretrovirals and HIV care in the United States.
Cohn J. Cohn J. Ann Intern Med. 2013 May 21;158(10):777. doi: 10.7326/0003-4819-158-10-201305210-00017. Ann Intern Med. 2013. PMID: 23689771 No abstract available.
Generic antiretrovirals and HIV care in the United States--in response.
Sherer R. Sherer R. Ann Intern Med. 2013 May 21;158(10):777-8. doi: 10.7326/0003-4819-158-10-201305210-00018. Ann Intern Med. 2013. PMID: 23689772 No abstract available.

Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States.
Walensky RP, Sax PE, Nakamura YM, Weinstein MC, Pei PP, Freedberg KA, Paltiel AD, Schackman BR. Walensky RP, et al. Ann Intern Med. 2013 Jan 15;158(2):84-92. doi: 10.7326/0003-4819-158-2-201301150-00002. Ann Intern Med. 2013. PMID: 23318310 Free PMC article.